Search Criteria : United States of America Rochester
Sep 30 - Oct 02, 2020 | CME 17.25 | Rochester, Minnesota
Internal Medicine and General Medicine | Hematology Blood and Marrow Transplant | Vascular Surgery | Nursing ...
This conference has been CANCELLED. Bleeding and Thrombosing Diseases Conference and Workshop is organized by Mayo Clinic Laboratories (MCL) and will be held from Sep 30 - Oct 02, 2020 at Rochester, Minnesota, United States of America. Additional details will be posted as soon as they are available.
This conference has been CANCELLED. Non Malignant Hematology Conference is organized by Mayo Clinic Laboratories (MCL) and will be held from Oct 02 - 03, 2020 at Rochester, Minnesota, United States of America. Additional details will be posted as soon as information is available.
Oct 21 - 22, 2020 | Rochester, Minnesota
Due to concerns related to COVID-19, the Center for Individualized Medicine has canceled the 2020 Individualizing Medicine Conference. Individualizing Medicine Conference is organized by Mayo Clinic and will be held from Oct 21 - 22, 2020 at Mayo Civic Center, Rochester, Minnesota, United States of America. Who Should Attend: • Physicians • Bioinformaticians • Clinician-researchers and scientists • Nurse practitioners and physician assistants • Nurses • Any other interested members of the health care team Description: Personalized medicine is driving new diagnostics and therapeutics into practice every day. The Mayo Clinic Individualizing Medicine Conference offers the opportunity to learn from experts and see first-hand how this field is impacting clinical practice, research, and education. Individualized medicine leaders discuss emerging topics such as: • Harnessing the Power of Omics Data and Artificial Intelligence • Advances in Rare Disease • Gene Therapy • Scalable Genomics • Infectious Disease and Advances through the Microbiome • Precision Cancer Care • Individualized Medicine Applied to Obesity • and MORE! Keynote speakers, networking opportunities and practical concurrent sessions will help you gain the knowledge to lead change in precision medicine in your own team and organization. Reasons to Attend: • Attendees DISCOVER advanced applications of targeted therapies, advancing care through genomics • Expert speakers from Mayo Clinic and around the world INSPIRE attendees through practical application-based presentations • Opportunities to CONNECT with others in the field and explore future collaboration • Innovative, quality content at a beautiful location for a great VALUE Attendees Also: • Learn practical applications for integrating molecular diagnostics and immunotherapy to individualize patient care • Discuss strategies to overcome obstacles of implementing individualized therapies for patient care • Discuss immunotherapeutic technology applications, impact on health care delivery, and implications for patients and medical professionals • Learn about visionary research and discoveries in precision cancer care • Network with professionals in your field
Oct 22 - 24, 2020 | CME 23 | USD $3,900.00 | Rochester, Minnesota
Mayo Clinic Healthy Living Program for Physicians is organized by Mayo Clinic and will be held from Oct 22 - 24, 2020 at Dan Abraham Healthy Living Ctr, Rochester, Minnesota, United States of America. Target Audience: Mayo Clinic physicians and experts in the areas of wellness, physical activity, nutrition and resiliency designed this course to equip you with the skills necessary to develop individualized wellness plans for yourself, and your patients. Physicians practicing internal medicine, primary care/family medicine, preventive medicine, cardiovascular medicine and endocrinology will find this information applicable to practice. Accreditation: AMA Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 23 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ABIM Maintenance of Certification Points Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 23 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. American Academy of Family Physicians This Live activity, Healthy Living Program for Physicians, from 01/09/2020 - 10/24/2020, has been reviewed and is acceptable for up to 22.75 Prescribed credit(s) by the American Academy of Family Physicians. Description: Be one of the first to experience Mayo Clinic Healthy Living Program for Physicians, a new offering uniquely designed by and for physicians like you. With rising rates of physician burnout, invigorate your knowledge of and commitment to physical activity, nutrition, and resiliency and the mind-body connection through an immersive experience that will benefit you and your patients. Based on The Mayo Clinic Healthy Living Program principles, you will learn how lifestyle medicine can prevent and treat chronic disease and improve quality of life. Unlike traditional CME that uses classroom-based formats to educate physicians, this course offers active, hands-on learning and the creation of an individualized wellness plan. Learning in this personal manner will allow you to better guide patients to make similar healthy behavior changes. Comprehensive Education: • Evidence-based comprehensive wellness program • Experience a personal physical activity assessment, which includes: body composition scan, cardiovascular stress test, movement assessment, strength assessment, physician-led assessment review and a cardiovascular and resistance training plan • Small group sessions, only 15 spaces available per session • One-on-one session with wellness experts: physicians, wellness physical therapists, wellness exercise specialists, certified wellness coaches and dietitian • Learn how to guide your patients on their own wellness journey Learning Objectives: Upon conclusion of this program, participants should be able to: • Recognize the relationship between health behaviors, chronic disease and quality of life. • Assess patient wellness in their own clinical practice. • Create your own individualized wellness plan. • Demonstrate tracking health behaviors. Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Oct 26 - 28, 2020 | Rochester, Minnesota
The digital 2nd Allogeneic Cell Therapies Summit is the only meeting completely focussed on advancing the development of off-the-shelf therapies by advancing cryopreservation techniques and decreasing cost through industrialized manufacturing. Network with 250 industry leaders to discuss novel genetic engineering techniques that overcome rejection and avoid GVHD to pave the way for further breakthroughs in patient treatment. Prices:Conference + 2 Workshops (Drug Developer Early Registration Rate): USD 2517.00,Conference + 1 Workshop (Drug Developer Early Registration Rate): USD 2168.00,Conference Only (Drug Developer Early Registration Rate): USD 1819.00,Workshop Only (Drug Developer Early Registration Rate): USD 489.00,Conference + 2 Workshops (Drug Developer Standard Rate): USD 3007.00,Conference + 1 Workshop (Drug Developer Standard Rate): USD 2588.00,Conference Only (Drug Developer Standard Rate): USD 2169.00,Workshop Only (Drug Developer Standard Rate): USD 489.00 Speakers: Jo Brewer VP, Allogeneic Research Adaptimmune, Anthony Colenburg Director of Quality Adicet Bio, Peter Flynn CTO Artiva Biotherapeutics, Blake Aftab VP, Preclinical and Translational Science Atara Biotherapeutics, Manny Duenas VP, Head of Global Market Access Atara Biotherapeutics, Maksim Mamonkin Assistant Professor Baylor College of Medicine, Joy Aho Senior Product Manager Be The Match BioTherapies, Ian McNiece CSO Biocardia, Aura Mackenzie Senior Director Bluebird Bio, Robert Deans CIO Bluerock Therapeutics, Katie Pollock Head of Formulation and Cryobiology Bristol-Myers Squibb, Olivier Godeaux CMO Bone Therapeutics, Jean-Pierre Latere COO Celyad, Elizabeth Garner Principal Scientist Caribou Biosciences, Luis Borges CSO Century Therapeutics, Demetrios Kalaitzidis Director, ImmunoOncology CRISPR Therapeutics, Bob Valamehr CDO Fate Therapeutics, Oliver Nussbaumer Head of Immunology GammaDelta Therapeutics, Dominic Clarke Global Head of Cell Therapy HemaCare Corporation, Yannick Bulliard Director, Translational Science Immatics, Lawrence Lamb CSO Incysus Therapeutics, Chris Bond VP, Cellular Engineering Kite Pharma, Andy Snowden Senior Director, Process Development Kite Pharma, Marcos Langtry Head of Allogeneic Cell Therapy Commercial Development Lonza Pharma and Biotech, Jean-François Chaubard CTO MaSTheCell, Tamara Laskowski Senior Research Scientist, Immunotherapy MD Anderson Center, Meisam Naeimi Postdoctoral Fellow Nationwide Children's Hospital, Hans Klingemann VP, R and D NantKwest, Guanglin Yu Senior Scientist Novartis, Sumithira Vasu Associate Professor The Ohio State University, Stacey Cranert Senior Scientist Poseida Therapeutics, Chris Heery CMO Precision BioSciences, Dan MacLeod Head of Cell Therapy Precision Biosciences, Jonathan Gilbert Head of Business Development SQZ Biotechnologies, Chelsea Xue Director, Head of Analytics, Cell Therapy Takeda, Lan Cao Senior Director, Head of Product Development and Global Program Leader, Cell Therapy Takeda, Dario Gutierrez VP, Discovery, Research and Innovation TCR2 Therapeutics , Michael Leek CEO TCBiopharm, Bruce Bunnell Professor and Director Tulane University of Louisiana, Evren Alici CEO Vycellix
Oct 29 - 30, 2020 | Credit 16 | USD $1,450.00 | Rochester, Minnesota
International Symposium Mayo Clinic Model of Care 2020 is organized by Mayo Clinic and will be held from Oct 29 - 30, 2020 at Mayo Clinic - Siebens Building - Phillips Hall, Rochester, Minnesota, United States of America. Target Audience: This symposium is designed for international clinicians, health care executives, administrators and business leaders. Participants should be able to understand English. Accreditation: 16.00 Attendance Description: Mayo Clinic has been dedicated to international collaboration for over 100 years, starting with the Mayo brothers, who traveled throughout the world to share medical practices and learn from others. We are honored to continue this tradition with you. Mayo Clinic is pleased to announce a two-day symposium for international medical leaders designed to provide in-depth exposure to the mission, values and systems that have made Mayo Clinic a recognized leader in medicine worldwide. Mayo Clinic senior leadership will share insights on: • The value principles that make up the Mayo Model of Care • The business and management systems that support Mayo's integrated practice • The culture of service excellence that sustains Mayo's ranking as one of the best hospitals in America Through presentations, tours, open discussions, and question and answer sessions, participants will gain a cohesive understanding of Mayo Clinic's integrated model of health care delivery. Whatever your role in health care, we hope you'll find value and new ideas at the symposium. We expect to learn as much from you as you do from us. Learning Objectives: Upon conclusion of this program, participants should be able to: • Identify the value principles that make up the Mayo Model of Care • Describe the business and management systems that support Mayo’s integrated practice • Recognize the culture of service excellence that sustains Mayo’s ranking as one of the best hospitals in America • Recognize leadership principles and the culture of collaboration and a team-based health care structure.
Nov 02 - 06, 2020 | USD $7,395.00 | Rochester, Minnesota
Mayo Clinic Healthcare Leader Intensive Course is organized by Mayo Clinic and will be held from Nov 02 - 06, 2020 at Hilton Rochester Mayo Clinic Area, Rochester, Minnesota, United States of America. Target Audience: This course is designed for physicians, executives and other leaders within healthcare organizations around the world. Overview: This course provides international healthcare leaders an intensive, all-inclusive experience. Attendees will be immersed in both didactic and interactive experiences with Mayo Clinic leaders across patient care, research and education. Topics include the Mayo Clinic Model of Care and its integrated healthcare practice and demonstrations of the best-in-class Mayo patient experience. Attendees will learn from and network with innovative leaders in areas such as Individualized Medicine, Regenerative Medicine, Practice Innovation and Quality. A full schedule will be released at registration. Learning Objectives: Upon conclusion of this program, participants should be able to: • Gain insights into the operations of an integrated healthcare practice • Learn leadership and administrative skills that can be used at your organization • Discover the best practices that have established Mayo Clinic as a trusted healthcare provider Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course. Additional details will be posted as soon as information is available.
Nov 06 - 07, 2020 | Rochester, Minnesota
30th Annual Mayo Clinic Symposium on Sports Medicine 2020 is organized by Mayo Clinic and will be held from Nov 06 - 07, 2020 at Hilton Rochester Mayo Clinic Area, Rochester, Minnesota, United States of America. Course Description: This course continues to feature evidence-based and cutting edge diagnostic and treatment strategies for sports-related and musculoskeletal conditions. The program is multidisciplinary, with expert lecturers representing a spectrum of sports medicine fields. Multiple educational formats are used, including case presentations, interactive Q&A sessions, live demonstrations of physical examination, anatomy, ultrasound and arthroscopy. Additional details will be posted as soon as information is available.
May 08, 2021 | USD $300.00 | Rochester, Minnesota
Mayo Clinic Workshop in Plasma Cell Disorders: Robert Kyle Symposium 2021 is organized by Mayo Clinic and will be held on May 08, 2021 at Mayo Civic Center, Rochester, Minnesota, United States of America. Target Audience: This course is designed for Physicians, Physician Assistants, Nurse Practitioners and Nurses. Description: There are numerous new and established drug therapies and protocols for plasma cell disorders, including AL amyloidosis, Waldenstrom’s macroglobulinemia and multiple myeloma. This one-day CME course introduces health care professionals at all levels to the latest practices in the treatment of plasma cell disorders. The conference provides “bench-to-bedside” overview of novel drug therapies for the general oncologist, resident, fellow, or advanced practice provider who is unfamiliar with current clinical trials and treatments Patient Symposiums: Concurrent with the scientific program for physicians and healthcare professionals, there will be a separate patient-oriented symposium. Registration for the patient symposium is free for patients and their family members. Register at this site. Learning Objectives: Upon conclusion of this program, participants should be able to: • Interpret new, practice-relevant data in diagnosing and risk stratifying monoclonal plasma cell disorders. • Integrate evidence-based treatment strategies into clinical practice for Monoclonal gammopathies. • Integrate supportive care approaches into treatment of plasma cell disorders . Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course. Course Highlights: • Panel discussions with top researchers and clinicians who are leading clinical trials that will benefit patients seen by attendees • Content directly focused on the types of clinical cases general hematologists/oncologists are seeing in their clinics and hospitals • Q&A with faculty about real clinical scenarios • Special recognition of Dr. Robert Kyle, Mayo Clinic emeritus, who will be present and speak at the event.
Jun 17 - 19, 2021 | CME 15.75 | USD $795.00 | Rochester, Minnesota
2021 8th Revision Hip & Knee Course Course is organized by International Congress for Joint Reconstruction (ICJR) and will be held from Jun 17 - 19, 2021 at Hilton Rochester Mayo Clinic Area, Rochester, Minnesota, United States of America. Target Audience: Orthopaedic surgeons and other healthcare professionals who have ample experience in primary hip and knee arthroplasty and those who want to become more proficient in revision hip and knee arthroplasty procedures. Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Foundation for Orthopaedic Research & Education (FORE) and International Congress for Joint Reconstruction (ICJR). FORE is accredited by the ACCME to provide continuing medical education for physicians. FORE designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Description: This is the ideal course for you if you’re already experienced in primary hip and knee arthroplasty and now want to learn how you can expand your skills in revision procedures. The expert faculty will share the knowledge, principles, and skills they have acquired in their busy revision practices to address a variety of topics, including: • Extensile exposures • Component removal techniques • Options for treating periprosthetic infection • Evaluation of metal hypersensitivity • Component selection • Management of extensor mechanism injury • During the bioskills labs, you will have the opportunity for hands-on learning under the direction of some of the top revision surgeons in the country. Objectives: • Discuss clinical, radiographic, and laboratory evaluation of a patient who presents with a painful or failed hip or knee arthroplasty • Evaluate sources of pain to establish a differential diagnosis and discuss appropriate treatment options • Identify potential challenges in a revision hip or knee procedure and demonstrate the ability to prepare a preoperative plan that includes evaluation of the appropriate surgical intervention, anticipated blood loss, and necessary implants, bone grafts, and removal tools • Compare and contrast options to safely and effectively remove existing prosthetic devices while minimizing blood and bone loss and avoiding compromise of motor function, neurovascular injury, and infection • Discuss the principles necessary to obtain fixation and restore joint stability, kinematics, and function in a revision hip or knee arthroplasty • Demonstrate removal of well-fixed hip and knee components and cement from cadaveric specimens • Demonstrate extensile approaches to revision hip or knee arthroplasty, including the extended trochanteric osteotomy and the tibial tubercle osteotomy, in cadaveric specimens • Evaluate reconstructive options that allow management of bone loss with restoration of maximum mobility • Identify the steps in evaluating and diagnosing a periprosthetic joint infection in hip and knee arthroplasty patients, including the emerging use of advanced molecular diagnostic tools • Describe the role of I&D with component retention and subsequent antibiotic suppression therapy in managing acute periprosthetic joint infection in hip and knee arthroplasty patients • Discuss the pros and cons of articulating versus non-articulating antibiotic spacers in a 2-stage exchange for an infected total hip arthroplasty and articulating versus static antibiotic spacers in a 2-stage exchange for an infected total knee arthroplasty